Inclusion Criteria:  ≥18，Advanced Non-small Cell Lung Cancer Confirmed by Histopathology Patients received platinum-based chemotherapy combined with immunotherapy  Exclusion Criteria:  EGFR/ALK/ROS1 driver gene mutation Chemotherapy only Concurrent radio-chemotherapy Surgery Single-agent immunotherapy No treatment information available